Book summary “Mad in America”: summary

Introduction

You live in a society that trusts modern psychiatry to heal mental illness with advanced medications. Yet you may notice that psychiatric disability rates keep climbing despite decades of supposedly breakthrough treatments. You wonder why so many patients fail to recover fully and instead remain chronic psychiatric patients for life.

Robert Whitaker argues that modern psychiatry has systematically substituted social control and toxic drugs for genuine healing. The author traces this failure from early asylum brutality and moral treatment through eugenics, shock therapies, and the neuroleptic revolution. You will discover how biological psychiatry manufactured a false narrative of chemical imbalances to justify permanent chemical restraints.

The book answers critical questions about the history of psychiatry:

• How did humanitarian asylums degenerate into chambers of forced sterilization and torture?
• What evidence proves that modern psychotropic drugs worsen long-term recovery rates?
• Why did the medical establishment ignore signs of permanent brain damage caused by neuroleptics?

1. Brutal Beginnings and Moral Treatment

Seventeenth and eighteenth-century European medical theories regarded the insane as brutes who had lost their reason and possessed superhuman strength. Physicians like Thomas Willis and Richard Mead argued that because the insane descended to an animal-like state, they required physical subjugation, fear, threats, fetters, and beatings.

Early asylum psychiatry relied on physical subjugation and terror before humanitarian reformers introduced moral treatment.

The Brutish View of Insanity

Asylum doctors utilized physically depleting and painful medical therapies to weaken mad patients, induce terror, and distract their minds from delusional thoughts. You can trace these standard treatments across early institutions:

• bleed patients to the point of fainting;
• administer repeated purges and nausea-inducing emetics;
• apply mustard powders and caustics to create painful blisters on the scalp.

John Monro, superintendent of Bethlehem Asylum, administered sixty-one vomit-inducing emetics to a single patient in six months. European and American mad-doctors also invented terror-inducing mechanical devices, water shocks, and near-drowning procedures designed to break the patient's will.

Benjamin Rush introduced European medical methods to America, treating madness as a circulatory disorder through extreme bloodletting and mechanical restraining devices. Rush drew 200 ounces of blood from a single patient in less than two months and bled another manic patient forty-seven times.

The Rise of Moral Treatment

Moral treatment originated as a humanitarian rejection of brutal physical restraints and harsh medical therapeutics used on the insane. Philippe Pinel in France and Jean Baptiste Pussin observed that aggressive psychiatric symptoms were primarily protests against inhumane treatment. In 1793, physician Philippe Pinel was appointed to tend to the insane at Salpêtrière and Bicêtre asylums, where more than half of the men admitted had died within a year.

The Quakers at the York Retreat developed a non-medical, faith-based asylum approach relying on gentleness, fresh air, useful activity, and respect. In 1791, Hannah Mills died of ill treatment at the York asylum, prompting the Quakers to open their retreat in 1796. During its first fifteen years, the York Retreat achieved a 70 percent recovery rate for patients ill for less than twelve months.

Early nineteenth-century American society embraced moral treatment within small, privately funded asylums that mirrored democratic ideals. In 1817, Philadelphia Quakers opened the first moral-treatment asylum in America, followed by a public asylum in Worcester, Massachusetts, in 1833. By 1841, there were sixteen moral-treatment asylums in the United States, and McLean Hospital discharged 59 percent of its patients as recovered or improved between 1818 and 1830.

Thomas Kirkbride successfully maintained a rigorous moral treatment model at Pennsylvania Hospital for over four decades. Born on July 31, 1809, Kirkbride opened the hospital's new countryside asylum in 1841 and maintained an 1,100-volume reading parlor while relying on a dedicated ward system.

2. Eugenics and State Asylums

As states funded public asylums, medical societies successfully lobbied to ensure doctors were appointed as superintendents. Physicians argued that mental illness stemmed from irritated or worn-out nerves caused by civilization, justifying moral treatment while simultaneously reintroducing medical drugs and physical restraints.

The corruption of moral treatment by medical superintendents led directly into eugenic sterilization and horrific asylum conditions.

The Utica Lunatic Asylum in New York devised a claustrophobic crib with a hinged lid for confining disruptive patients at night.

You can trace how institutional interest shaped daily routines through specific administrative rules:

• Appoint a physician as the chief executive officer and superintendent of every asylum
• Employ mild cathartics, bloodletting, and sedative drugs such as morphine and opium
• Use physical restraints such as mitts, straitjackets, and cribs when deemed necessary by institutional interest

Dorothea Dix successfully pressured states to build numerous asylums, causing patient populations to swell far beyond recommended limits. The success rate of patients ill less than a year at Worcester asylum dropped from 80 percent in its first decade to 67 percent in its second decade. By 1880, there were 139 mental hospitals in the country holding 74,000 patients.

The Rise of Eugenics and Sterilization

Sir Francis Galton founded eugenics by applying Darwinian evolution to humans, arguing that intelligence and social success are entirely inborn. He coined the term eugenics in 1883 to describe a science aimed at multiplying the fit and suppressing the unfit. Wealthy elites like Andrew Carnegie and John D. Rockefeller Jr. provided financial support to establish research centers like the Eugenics Record Office at Cold Spring Harbor.

Aaron Rosanoff studied seventy-two insane patients and claimed that relatives who were merely high-strung or stubborn should be classified as neuropathic. State legislatures enacted compulsory sterilization laws for the mentally ill, culminating in the 1927 U.S. Supreme Court ruling that constitutionalized the practice.

Indiana passed the first compulsory sterilization law in 1907, and Oliver Wendell Holmes authored the 1927 Supreme Court decision upholding Virginia's sterilization statute. By the end of 1945, 45,127 Americans were sterilized under such laws, with 21,311 of those individuals being patients in state mental hospitals.

3. Shock Therapies and Psychosurgery

Physicians embraced brain-damaging therapies like insulin comas, electroshock, and prefrontal lobotomy as miraculous cures.

Asylum doctors introduced hydrotherapy units featuring continuous baths, needle showers, and wet packs as physiological regulators of body heat and fatigue. Edward Strecker of the Pennsylvania Hospital reported in 1917 that patients could be kept in continuous baths for weeks, and a California investigation reviewed brutal wet packs in 1919.

Asylum medicine experimented with extreme temperatures, intentionally inducing high fevers or deep hibernation to treat psychosis. Harvard physicians John Talbott and Kenneth Tillotson placed ten schizophrenic patients in refrigerant-cooled blankets, resulting in one death. Ohio doctors Douglas Goldman and Maynard Murray later abandoned refrigeration therapy after three of sixteen patients died.

Bounty of Physical Remedies

Dr. Henry Cotton claimed staggering cure rates by surgically removing body parts under the theory that hidden bacterial infections caused mental illness. Cotton systematically extracted teeth, tonsils, colons, and gall bladders.

An inquiry launched in 1924 by the Trenton State Hospital board uncovered that Cotton had killed more than 100 patients with his intestinal surgeries alone.

Pioneered by Manfred Sakel, insulin-coma therapy deliberately starved the brain of sugar to induce repeated hypoglycemic comas, destroying cortical cells. Sakel discovered that heavy doses of insulin plunged patients into dangerous comas that wiped out higher intellectual functions, leaving them in a childlike state.

A 1950 Ohio study found that only 6 percent of patients remained socially recovered after three years, and up to 80 percent of insulin-treated patients eventually had to be readmitted.

Metrazol convulsive therapy induced violent, bone-breaking seizures in psychiatric patients under the premise that artificially triggered epilepsy could drive out schizophrenia. Ladislas von Meduna popularized metrazol injections as chemical dynamite to shatter pathological mental processes. By 1939, 70 percent of U.S. hospitals used metrazol, and 37,000 Americans underwent the treatment between 1936 and 1941.

Ugo Cerletti's electroshock therapy applied electric current directly to the brain to induce grand mal seizures, substituting physical brain trauma for behavioral control. Cerletti performed his first human electroshock experiment in Rome in 1938, using 110 volts to induce a seizure in patient S.E. An estimated total of one million Americans were subjected to forced electroshock.

The Rise of Lobotomy

Prefrontal lobotomy was introduced as a way to surgically disable the frontal lobes, which were identified as the center of higher human intelligence. Egas Moniz developed lobotomy based on the theory that psychiatric disorders stemmed from fixed, pathological thoughts.

Walter Freeman and James Watts aggressively popularized lobotomy in the United States, utilizing media campaigns to frame the procedure as a miraculous cure. Freeman developed the simplified transorbital lobotomy technique in 1946, turning the procedure into an office procedure performed with an ice pick.

• 20,000 Americans underwent lobotomy in the decade following World War II.
• Freeman charged a fee of $25 per asylum operation when traveling with his station wagon.

4. The Neuroleptic Revolution

Chlorpromazine was introduced as a chemical lobotomy, quickly rebranded as a wonder drug through aggressive marketing and flawed science.

Introduction of Chlorpromazine

When Rhône-Poulenc synthesized chlorpromazine in 1950, researchers viewed it as a physical restraint rather than a curative agent. French naval surgeon Henri Laborit and psychiatrists Jean Delay and Pierre Deniker observed that the compound induced profound emotional indifference. When Smith, Kline & French introduced chlorpromazine as Thorazine to the U.S. market in May 1954, American clinician N. William Winkelman Jr. noted that the drug produced effects similar to frontal lobotomy.

Early psychiatrists noticed severe motor side effects and debated whether inducing these disabilities was essential for success. Swiss psychiatrist Hans Steck announced in 1954 that 37 percent of 299 treated patients showed Parkinsonian signs. New York psychiatrist Hyman Pleasure reported that two-thirds of his patients showed similar symptoms.

Marketing and Corporate Influence

Smith, Kline & French spent $350,000 developing chlorpromazine and tested it on 5,000 animals according to Francis Boyer. The FDA approved the drug on March 26, 1954, after administrators evaluated its effects on 150 psychiatric patients.

The company launched a national television show titled "The March of Medicine" in March 1954 to promote the drug. State governments eagerly embraced the new model because 500,000 people lived in public asylums at $2 per day per patient, driving annual state expenditures to $500 million.

Corporate money soon penetrated medical institutions:

• in 1950, the AMA received $2.6 million from drug ads compared to $5 million from member dues;
• a decade later, drug company revenue leaped to $10 million while dues remained around $6 million.

The Durham-Humphrey Amendment of 1951 restricted potent medications to prescriptions, increasing physician status and corporate marketing budgets. Senator Estes Kefauver initiated a two-year investigation in 1959 into drug-industry practices, where Pfizer physician Haskell Weinstein confessed that ghostwriting produced numerous scientific papers.

The National Institute of Mental Health cemented the new paradigm with a 1961 study involving 270 drug-treated schizophrenics across nine hospitals. Federal spending on mental-health research surged from $10.9 million in 1953 to $100.9 million in 1961.

5. The Biological Mechanism of Harm

Long-term neuroleptic exposure blocks D2 receptors, creating dopamine supersensitivity and permanent brain damage.

Pharmacologist Arvid Carlsson determined in 1963 that neuroleptics inhibit dopamine activity. Standard neuroleptics occupy 70 percent to 90 percent of all D2 receptors at therapeutic doses. You will find that these drugs impair vital dopaminergic nerve pathways instead of normalizing brain chemistry.

The Dopamine Hypothesis Debunked

Psychiatric theories of mental illness have historically been invented to justify existing treatments. Researchers in the 1970s proved that unmedicated schizophrenics do not have abnormally high levels of dopamine. Malcolm Bowers found normal dopamine metabolite levels in unmedicated schizophrenics at Yale in 1974. Robert Post found no elevation in twenty nonmedicated patients at the National Institute of Mental Health in 1975.

Blocking D2 receptors makes the brain supersensitive to dopamine. Philip Seeman and Tyrone Lee reported 50 percent or more dopamine receptors in autopsies by 1978. Antipsychotics induce the same brain abnormalities as angel dust by increasing high-affinity D2 receptors. Seventy percent of individuals with schizophrenia are supersensitive to dopamine after being medicated.

Long-term MRI studies reveal that antipsychotic medications cause structural brain changes. Raquel Gur reported that swelling of the basal ganglia and thalamus is linked to symptom severity. Nancy Andreasen tracked 500 newly diagnosed schizophrenia patients starting in 1989 and found progressive frontal lobe white matter volume reduction over time. Andreasen conceded in a 2008 interview with the New York Times that medication causes brain tissue loss.

Tardive Dyskinesia and Permanent Damage

French psychiatrists first reported tardive dyskinesia symptoms in 1959. Five percent of patients develop tardive dyskinesia within one year of neuroleptic treatment, and the risk increases an additional 5 percent each year. You face an increased risk of frontal atrophy for each ten grams of neuroleptics taken, calculated at 6.5 percent.

Patients experience profound subjective distress and view the drugs as chemical restraints. Janet Gotkin received a cumulative dose of 1 million milligrams of neuroleptics over a ten-year period and testified at 1975 Senate hearings about being trapped inside a drug-induced fog.

You must recognize the primary features of neuroleptic toxicity:

• tardive dyskinesia;
• neuroleptic malignant syndrome;
• akathisia;
• akinesia;
• zombie juice.

Estimates indicate that 100,000 Americans died from neuroleptic malignant syndrome from 1960 to 1980. Mantosh Dewan and other researchers observed that mortality rates dropped from 22 percent to 4 percent once the condition became a recognized topic of concern.

6. Human Experimentation and Atypicals

Government-funded researchers subjected patients to unethical symptom-exacerbation trials while pharmaceutical companies marketed dirty atypical drugs.

Symptom-Exacerbation Studies

Postwar psychiatrists bypassed ethical standards to test the dopamine hypothesis by administering stimulants to intentionally worsen psychotic symptoms. David Janowsky reported in 1973 that amphetamine injections rapidly intensified psychotic symptoms. Public records revealed that researchers misled patients in consent forms.

Dr. Michael Davidson told patients his L-dopa studies measured blood hormones while concealing the risk of toxic psychosis. Researchers by the mid-1980s ran government-funded trials involving 750 mentally ill people.

Shalmah Prince went to a Cincinnati hospital in 1983 for help with minor edginess, was taken off lithium, injected with apomorphine, suffered a severe manic break, and was left tied in leather restraints for three days.

Public outcry led by advocacy groups like Circare forced the NIMH to halt multiple symptom-exacerbation studies in the late 1990s. Fifty years of human experimentation produced zero clinical advancements or diagnostic tools for understanding schizophrenia.

The Atypical Antipsychotic Fraud

Independent clinical trials demonstrated that second-generation atypical antipsychotics are no more effective than older standard neuroleptics.

Drug companies hired for-profit research sites to bypass traditional academic oversight. Spending by pharmaceutical companies for research services soared from under $1 billion in 1990 to $3.5 billion in 2000.

Richard Borison and Bruce Diamond secured 160 contracts worth over $10 million by operating outside medical school oversight. They used millions from pharmaceutical contracts to buy luxury items, including plans for an 11,000-square-foot castle with a moat, medieval armor, and antique stone lions.

Clinical trials required washout protocols where existing medications were abruptly stopped to establish active disease. At least 36 people in the studies of risperidone, olanzapine, quetiapine, and sertindole killed themselves.

Eli Lilly's olanzapine achieved blockbuster status with U.S. sales topping $1 billion in 1998, despite patients gaining nearly a pound a week in short-term trials. Physicians began prescribing these drugs to toddlers and at-risk teenagers.

In the NIMH-funded CATIE trial involving 1,493 patients, 74 percent had to discontinue their assigned drug due to intolerable side effects or lack of efficacy. Discontinuation rates were identical between older perphenazine and atypicals.

Conclusion

Modern psychiatry has systematically substituted social control and toxic drugs for genuine healing, worsening long-term outcomes for millions of patients through institutional hubris and profit motives.

You now see how historical experiments, chemical revolutions, and corporate interests trap vulnerable people in cycles of chronic illness. To navigate this system, you must approach psychiatric claims with rigorous skepticism and demand genuine humanistic alternatives.

1. Question the chemical imbalance myth by researching the actual long-term data on psychotropic medications.
2. Investigate non-drug sanctuary models like Soteria House that prioritize human connection over physical restraint.
3. Support policies that demand independent oversight of clinical trials and strip pharmaceutical companies of marketing influence.
4. Protect yourself and your loved ones by seeking informed consent about the permanent neurological risks of psychiatric drugs.

10 Key Ideas

1. Early asylum psychiatry relied on physical subjugation and terror before humanitarian reformers introduced moral treatment.
2. The corruption of moral treatment by medical superintendents led directly into eugenic sterilization and horrific asylum conditions.
3. Physicians embraced brain-damaging therapies like insulin comas, electroshock, and prefrontal lobotomy as miraculous cures.
4. Chlorpromazine was introduced as a chemical lobotomy, quickly rebranded as a wonder drug through aggressive marketing and flawed science.
5. Long-term neuroleptic exposure blocks D2 receptors, creating dopamine supersensitivity and permanent brain damage.
6. Psychiatric theories of mental illness have historically been invented to justify existing treatments.
7. Patients experience profound subjective distress and view the drugs as chemical restraints.
8. Government-funded researchers subjected patients to unethical symptom-exacerbation trials while pharmaceutical companies marketed dirty atypical drugs.
9. Independent clinical trials demonstrated that second-generation atypical antipsychotics are no more effective than older standard neuroleptics.
10. Modern psychiatry has systematically substituted social control and toxic drugs for genuine healing, worsening long-term outcomes for millions of patients through institutional hubris and profit motives.